World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
39730
World Ranking
8859
National Ranking
4561

Overview

Sergio Fazio is affiliated with Oregon Health & Science University in the United States. Their research primarily focuses on Medicine, with specific attention to subfields such as Surgery, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, and Cancer Research.

The main topics of Sergio Fazio's work include:

  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pharmaceutical Economics and Policy
  • Cancer, Lipids, and Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Acute Myocardial Infarction Research
  • Platelet Disorders and Treatments

Their recent publications cover a range of significant research including:

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020), published in European Heart Journal
  • Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary (2020), published in Endocrine Practice
  • Role of PAI-1 in hepatic steatosis and dyslipidemia (2021), published in Scientific Reports
  • Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1 (2022), published in Journal of Clinical Investigation
  • Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice (2021), published in Journal of Thrombosis and Haemostasis

Frequent co-authors in Sergio Fazio's research include:

  • Michael Szarek
  • Philippe Gabríel Steg
  • Gregory G. Schwartz
  • Deepak L. Bhatt
  • Vera Bittner

Their work has appeared most often in the following publication venues:

  • American Journal of Preventive Cardiology
  • Circulation
  • Journal of the American College of Cardiology
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Journal of clinical lipidology

Best Publications

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Current Perspectives on Statins

    David J. Maron;Sergio Fazio;MacRae F. Linton

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • Premature coronary-artery atherosclerosis in systemic lupus erythematosus.

    Yu Asanuma;Annette Oeser;Ayumi K. Shintani;Elizabeth Turner

  • AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

    Paul S. Jellinger;Yehuda Handelsman;Paul D. Rosenblit;Zachary T. Bloomgarden

  • Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

    Masato Furuhashi;Gürol Tuncman;Cem Z. Görgün;Liza Makowski;Liza Makowski

  • Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.

    Liza Makowski;Jeffrey B. Boord;Kazuhisa Maeda;Vladimir R. Babaev

  • Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.

    Michelle L. O’Donoghue;Sergio Fazio;Robert P. Giugliano;Erik S.G. Stroes

  • Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes

    Brian A. Ference;Jennifer G. Robinson;Robert D. Brook;Alberico L. Catapano

  • Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation

    MacRae F. Linton;James B. Atkinson;Sergio Fazio

  • Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.

    Tillmann Cyrus;Joseph L. Witztum;Daniel J. Rader;Rajendra Tangirala

  • HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

    Robert S. Rosenson;H. Bryan Brewer;M. John Chapman;Sergio Fazio

  • Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis

    Ebru Erbay;Vladimir R. Babaev;Jared R. Mayers;Liza Makowski

  • B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice

    Amy S. Major;Sergio Fazio;MacRae F. Linton

  • Residual Cardiovascular Risk Despite Optimal LDL-Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

    Uchechukwu K. Sampson;Sergio Fazio;MacRae F. Linton

  • Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice

    Michael E. Burleigh;Vladimir R. Babaev;John A. Oates;Raymond C. Harris

  • The forgotten lipids: Triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk

    Pratik B Sandesara;Salim S Virani;Salim S Virani;Sergio Fazio;Michael D Shapiro

  • Macrophages, inflammation, and atherosclerosis

    MacRae F Linton;Sergio Fazio

  • NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.

    Sotirios Tsimikas;Sergio Fazio;Keith C. Ferdinand;Henry N. Ginsberg

  • Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages

    Sergio Fazio;Vladimir R. Babaev;Alisa B. Murray;Alyssa H. Hasty

Frequent Co-Authors

MacRae F. Linton
MacRae F. Linton Vanderbilt University
Alyssa H. Hasty
Alyssa H. Hasty Vanderbilt University
Agnes B. Fogo
Agnes B. Fogo Vanderbilt University Medical Center
Wei Zheng
Wei Zheng Vanderbilt University Medical Center
Loren Lipworth
Loren Lipworth Vanderbilt University Medical Center
Qiuyin Cai
Qiuyin Cai Vanderbilt University Medical Center
Xiao-Ou Shu
Xiao-Ou Shu Vanderbilt University Medical Center
Gökhan S. Hotamisligil
Gökhan S. Hotamisligil Harvard University
Sotirios Tsimikas
Sotirios Tsimikas University of California, San Diego
William J. Blot
William J. Blot Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring medicine in the USA, there are several related online degrees that open doors to impactful health careers. Many professionals seek the fastest psychiatric nurse practitioner program to quickly transition into advanced mental health nursing roles, combining flexibility with high demand.

If you are interested in healthcare leadership, obtaining a health administration degree online is a popular choice. These programs equip graduates with skills for managing hospitals and other healthcare facilities, making them ideal for those aiming to impact healthcare systems.

Students seeking greater affordability can consider affordable online mha programs. These master's degrees in healthcare administration provide advanced management training without the heavy financial burden.

For nurses wanting to achieve the highest clinical credential, options like a 1 year dnp program online offer a fast track to leadership, advanced practice, and teaching positions within healthcare.

Each of these online pathways can complement or provide an alternative to traditional medical degrees, allowing greater flexibility and career diversity in the healthcare sector.

Best Scientists Citing Sergio Fazio

Trending Scientists